The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nuclear Medicine Cyclotron Systems Market Research Report 2025
Synopsis
A Radiochemistry PET Cyclotron is a specialized type of particle accelerator used in the production of positron-emitting radionuclides for use in positron emission tomography (PET) imaging. PET is a nuclear medicine imaging technique that provides detailed information about the functioning of organs and tissues in the body.
PET cyclotrons are essential in the production of short-lived positron-emitting radionuclides, such as fluorine-18 (F-18), carbon-11 (C-11), and nitrogen-13 (N-13), which have relatively short half-lives. The short half-lives mean that these radionuclides decay rapidly, making it essential to produce them on-site at medical facilities where PET imaging is performed.
The use of on-site cyclotrons for PET radionuclide production allows for a continuous supply of radiopharmaceuticals, which is crucial for conducting PET imaging studies in real-time and ensuring that patients receive fresh radiotracers for accurate and high-quality PET scans.
Global Nuclear Medicine Cyclotron Systems market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nuclear Medicine Cyclotron Systems market research.
The radiopharmaceuticals market had been experiencing steady growth and significant interest due to the increasing use of nuclear medicine procedures for diagnostic and therapeutic purposes. Radiopharmaceuticals are essential tools in nuclear medicine, and they play a crucial role in diagnosing various diseases, such as cancer, cardiovascular conditions, and neurological disorders.
The radiopharmaceuticals market had been growing steadily over the years. Factors contributing to this growth include advancements in radiopharmaceutical development, rising prevalence of cancer and cardiovascular diseases, and an aging population that drives the demand for diagnostic procedures.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nuclear Medicine Cyclotron Systems market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
IBA Radiopharma Solutions
Siemens Healthineers
GE Healthcare
Advanced Cyclotron Systems (ACSI)
Sumitomo Heavy Industries
Best Cyclotron Systems
Ionetix Corporation
isoSolution
Segment by Type
Low-Energy Cyclotrons
Medium-Energy Cyclotrons
High-Energy Cyclotrons
Segment by Application
Pharmaceutical Industry
Hospital
Research & Academics
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Nuclear Medicine Cyclotron Systems report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
A Radiochemistry PET Cyclotron is a specialized type of particle accelerator used in the production of positron-emitting radionuclides for use in positron emission tomography (PET) imaging. PET is a nuclear medicine imaging technique that provides detailed information about the functioning of organs and tissues in the body.
PET cyclotrons are essential in the production of short-lived positron-emitting radionuclides, such as fluorine-18 (F-18), carbon-11 (C-11), and nitrogen-13 (N-13), which have relatively short half-lives. The short half-lives mean that these radionuclides decay rapidly, making it essential to produce them on-site at medical facilities where PET imaging is performed.
The use of on-site cyclotrons for PET radionuclide production allows for a continuous supply of radiopharmaceuticals, which is crucial for conducting PET imaging studies in real-time and ensuring that patients receive fresh radiotracers for accurate and high-quality PET scans.
Global Nuclear Medicine Cyclotron Systems market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nuclear Medicine Cyclotron Systems market research.
The radiopharmaceuticals market had been experiencing steady growth and significant interest due to the increasing use of nuclear medicine procedures for diagnostic and therapeutic purposes. Radiopharmaceuticals are essential tools in nuclear medicine, and they play a crucial role in diagnosing various diseases, such as cancer, cardiovascular conditions, and neurological disorders.
The radiopharmaceuticals market had been growing steadily over the years. Factors contributing to this growth include advancements in radiopharmaceutical development, rising prevalence of cancer and cardiovascular diseases, and an aging population that drives the demand for diagnostic procedures.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nuclear Medicine Cyclotron Systems market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
IBA Radiopharma Solutions
Siemens Healthineers
GE Healthcare
Advanced Cyclotron Systems (ACSI)
Sumitomo Heavy Industries
Best Cyclotron Systems
Ionetix Corporation
isoSolution
Segment by Type
Low-Energy Cyclotrons
Medium-Energy Cyclotrons
High-Energy Cyclotrons
Segment by Application
Pharmaceutical Industry
Hospital
Research & Academics
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Nuclear Medicine Cyclotron Systems report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Index1 Nuclear Medicine Cyclotron Systems Market Overview
1.1 Product Definition
1.2 Nuclear Medicine Cyclotron Systems Segment by Type
1.2.1 Global Nuclear Medicine Cyclotron Systems Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Low-Energy Cyclotrons
1.2.3 Medium-Energy Cyclotrons
1.2.4 High-Energy Cyclotrons
1.3 Nuclear Medicine Cyclotron Systems Segment by Application
1.3.1 Global Nuclear Medicine Cyclotron Systems Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Pharmaceutical Industry
1.3.3 Hospital
1.3.4 Research & Academics
1.4 Global Market Growth Prospects
1.4.1 Global Nuclear Medicine Cyclotron Systems Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Nuclear Medicine Cyclotron Systems Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Nuclear Medicine Cyclotron Systems Production Estimates and Forecasts (2018-2029)
1.4.4 Global Nuclear Medicine Cyclotron Systems Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Nuclear Medicine Cyclotron Systems Production Market Share by Manufacturers (2018-2023)
2.2 Global Nuclear Medicine Cyclotron Systems Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Nuclear Medicine Cyclotron Systems, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Nuclear Medicine Cyclotron Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Nuclear Medicine Cyclotron Systems Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Nuclear Medicine Cyclotron Systems, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Nuclear Medicine Cyclotron Systems, Product Offered and Application
2.8 Global Key Manufacturers of Nuclear Medicine Cyclotron Systems, Date of Enter into This Industry
2.9 Nuclear Medicine Cyclotron Systems Market Competitive Situation and Trends
2.9.1 Nuclear Medicine Cyclotron Systems Market Concentration Rate
2.9.2 Global 5 and 10 Largest Nuclear Medicine Cyclotron Systems Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Nuclear Medicine Cyclotron Systems Production by Region
3.1 Global Nuclear Medicine Cyclotron Systems Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Nuclear Medicine Cyclotron Systems Production Value by Region (2018-2029)
3.2.1 Global Nuclear Medicine Cyclotron Systems Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Nuclear Medicine Cyclotron Systems by Region (2024-2029)
3.3 Global Nuclear Medicine Cyclotron Systems Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Nuclear Medicine Cyclotron Systems Production by Region (2018-2029)
3.4.1 Global Nuclear Medicine Cyclotron Systems Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Nuclear Medicine Cyclotron Systems by Region (2024-2029)
3.5 Global Nuclear Medicine Cyclotron Systems Market Price Analysis by Region (2018-2023)
3.6 Global Nuclear Medicine Cyclotron Systems Production and Value, Year-over-Year Growth
3.6.1 North America Nuclear Medicine Cyclotron Systems Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Nuclear Medicine Cyclotron Systems Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Nuclear Medicine Cyclotron Systems Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Nuclear Medicine Cyclotron Systems Production Value Estimates and Forecasts (2018-2029)
4 Nuclear Medicine Cyclotron Systems Consumption by Region
4.1 Global Nuclear Medicine Cyclotron Systems Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Nuclear Medicine Cyclotron Systems Consumption by Region (2018-2029)
4.2.1 Global Nuclear Medicine Cyclotron Systems Consumption by Region (2018-2023)
4.2.2 Global Nuclear Medicine Cyclotron Systems Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Nuclear Medicine Cyclotron Systems Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Nuclear Medicine Cyclotron Systems Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Nuclear Medicine Cyclotron Systems Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Nuclear Medicine Cyclotron Systems Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Nuclear Medicine Cyclotron Systems Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Nuclear Medicine Cyclotron Systems Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Nuclear Medicine Cyclotron Systems Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Nuclear Medicine Cyclotron Systems Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Nuclear Medicine Cyclotron Systems Production by Type (2018-2029)
5.1.1 Global Nuclear Medicine Cyclotron Systems Production by Type (2018-2023)
5.1.2 Global Nuclear Medicine Cyclotron Systems Production by Type (2024-2029)
5.1.3 Global Nuclear Medicine Cyclotron Systems Production Market Share by Type (2018-2029)
5.2 Global Nuclear Medicine Cyclotron Systems Production Value by Type (2018-2029)
5.2.1 Global Nuclear Medicine Cyclotron Systems Production Value by Type (2018-2023)
5.2.2 Global Nuclear Medicine Cyclotron Systems Production Value by Type (2024-2029)
5.2.3 Global Nuclear Medicine Cyclotron Systems Production Value Market Share by Type (2018-2029)
5.3 Global Nuclear Medicine Cyclotron Systems Price by Type (2018-2029)
6 Segment by Application
6.1 Global Nuclear Medicine Cyclotron Systems Production by Application (2018-2029)
6.1.1 Global Nuclear Medicine Cyclotron Systems Production by Application (2018-2023)
6.1.2 Global Nuclear Medicine Cyclotron Systems Production by Application (2024-2029)
6.1.3 Global Nuclear Medicine Cyclotron Systems Production Market Share by Application (2018-2029)
6.2 Global Nuclear Medicine Cyclotron Systems Production Value by Application (2018-2029)
6.2.1 Global Nuclear Medicine Cyclotron Systems Production Value by Application (2018-2023)
6.2.2 Global Nuclear Medicine Cyclotron Systems Production Value by Application (2024-2029)
6.2.3 Global Nuclear Medicine Cyclotron Systems Production Value Market Share by Application (2018-2029)
6.3 Global Nuclear Medicine Cyclotron Systems Price by Application (2018-2029)
7 Key Companies Profiled
7.1 IBA Radiopharma Solutions
7.1.1 IBA Radiopharma Solutions Nuclear Medicine Cyclotron Systems Corporation Information
7.1.2 IBA Radiopharma Solutions Nuclear Medicine Cyclotron Systems Product Portfolio
7.1.3 IBA Radiopharma Solutions Nuclear Medicine Cyclotron Systems Production, Value, Price and Gross Margin (2018-2023)
7.1.4 IBA Radiopharma Solutions Main Business and Markets Served
7.1.5 IBA Radiopharma Solutions Recent Developments/Updates
7.2 Siemens Healthineers
7.2.1 Siemens Healthineers Nuclear Medicine Cyclotron Systems Corporation Information
7.2.2 Siemens Healthineers Nuclear Medicine Cyclotron Systems Product Portfolio
7.2.3 Siemens Healthineers Nuclear Medicine Cyclotron Systems Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Siemens Healthineers Main Business and Markets Served
7.2.5 Siemens Healthineers Recent Developments/Updates
7.3 GE Healthcare
7.3.1 GE Healthcare Nuclear Medicine Cyclotron Systems Corporation Information
7.3.2 GE Healthcare Nuclear Medicine Cyclotron Systems Product Portfolio
7.3.3 GE Healthcare Nuclear Medicine Cyclotron Systems Production, Value, Price and Gross Margin (2018-2023)
7.3.4 GE Healthcare Main Business and Markets Served
7.3.5 GE Healthcare Recent Developments/Updates
7.4 Advanced Cyclotron Systems (ACSI)
7.4.1 Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems Corporation Information
7.4.2 Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems Product Portfolio
7.4.3 Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Advanced Cyclotron Systems (ACSI) Main Business and Markets Served
7.4.5 Advanced Cyclotron Systems (ACSI) Recent Developments/Updates
7.5 Sumitomo Heavy Industries
7.5.1 Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems Corporation Information
7.5.2 Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems Product Portfolio
7.5.3 Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Sumitomo Heavy Industries Main Business and Markets Served
7.5.5 Sumitomo Heavy Industries Recent Developments/Updates
7.6 Best Cyclotron Systems
7.6.1 Best Cyclotron Systems Nuclear Medicine Cyclotron Systems Corporation Information
7.6.2 Best Cyclotron Systems Nuclear Medicine Cyclotron Systems Product Portfolio
7.6.3 Best Cyclotron Systems Nuclear Medicine Cyclotron Systems Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Best Cyclotron Systems Main Business and Markets Served
7.6.5 Best Cyclotron Systems Recent Developments/Updates
7.7 Ionetix Corporation
7.7.1 Ionetix Corporation Nuclear Medicine Cyclotron Systems Corporation Information
7.7.2 Ionetix Corporation Nuclear Medicine Cyclotron Systems Product Portfolio
7.7.3 Ionetix Corporation Nuclear Medicine Cyclotron Systems Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Ionetix Corporation Main Business and Markets Served
7.7.5 Ionetix Corporation Recent Developments/Updates
7.8 isoSolution
7.8.1 isoSolution Nuclear Medicine Cyclotron Systems Corporation Information
7.8.2 isoSolution Nuclear Medicine Cyclotron Systems Product Portfolio
7.8.3 isoSolution Nuclear Medicine Cyclotron Systems Production, Value, Price and Gross Margin (2018-2023)
7.8.4 isoSolution Main Business and Markets Served
7.7.5 isoSolution Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Nuclear Medicine Cyclotron Systems Industry Chain Analysis
8.2 Nuclear Medicine Cyclotron Systems Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Nuclear Medicine Cyclotron Systems Production Mode & Process
8.4 Nuclear Medicine Cyclotron Systems Sales and Marketing
8.4.1 Nuclear Medicine Cyclotron Systems Sales Channels
8.4.2 Nuclear Medicine Cyclotron Systems Distributors
8.5 Nuclear Medicine Cyclotron Systems Customers
9 Nuclear Medicine Cyclotron Systems Market Dynamics
9.1 Nuclear Medicine Cyclotron Systems Industry Trends
9.2 Nuclear Medicine Cyclotron Systems Market Drivers
9.3 Nuclear Medicine Cyclotron Systems Market Challenges
9.4 Nuclear Medicine Cyclotron Systems Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
